Try
Cronos Group Inc.
CRONUnited States
49 filed reports · 803 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
49 reports · Dec 2017 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 6 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 20 | 4,191 | Mar 2020 to Jun 2026 |
| Current · 8-KSEC EDGAR | 19 | 56 | Dec 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 6 | 3,751 | Dec 2020 to Dec 2025 |
| Annual · 40-FSEC EDGAR | 2 | 799 | Dec 2017 to Dec 2018 |
| Annual · 10-K/ASEC EDGAR | 1 | 473 | Dec 2019 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 249 | Jun 2021 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 8 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 416 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 11, 2026 | 3 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 11, 2026 | 259 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 26, 2026 | 3 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,019 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 320 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 5 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 3 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 175 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 184 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 8, 2025 | 3 | Open |
Financial data
803 concepts · 9,519 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial729 concepts · 8,039 facts · Dec 2016 to Aug 2026
- Accumulated impairment charges49 · Dec 2019 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding weighted average exercise price49 · Dec 2016 to Jun 2026
- Revenue46 · Dec 2016 to Jun 2026
- Share based compensation arrangement by share based payment award options exercisable weighted average exercise price46 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents43 · Dec 2016 to Jun 2026
- Comprehensive income net of tax including portion attributable to noncontrolling interest43 · Dec 2017 to Jun 2026
- Gross profit (US GAAP)43 · Dec 2017 to Jun 2026
- Profit loss43 · Dec 2017 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding number43 · Dec 2016 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest43 · Dec 2016 to Jun 2026
- Allocated share based compensation expense39 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect39 · Dec 2017 to Jun 2026
- Comprehensive income net of tax39 · Dec 2017 to Jun 2026
- Comprehensive income net of tax attributable to noncontrolling interest39 · Dec 2017 to Jun 2026
- Cost of sales39 · Dec 2017 to Jun 2026
- Depreciation and amortization39 · Dec 2017 to Jun 2026
- Depreciation depletion and amortization39 · Dec 2017 to Jun 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents39 · Dec 2017 to Jun 2026
- Excise and sales taxes39 · Dec 2017 to Jun 2026
- General and administrative expense (US GAAP)39 · Dec 2017 to Jun 2026
- Income tax expense benefit39 · Dec 2017 to Jun 2026
- Increase decrease in accounts receivable39 · Dec 2017 to Jun 2026
- Increase decrease in inventories39 · Dec 2017 to Jun 2026
- Interest income expense nonoperating net39 · Dec 2017 to Jun 2026
Segment66 concepts · 1,129 facts · Dec 2016 to Jun 2026
- Revenue154 · Dec 2016 to Mar 2023
- Depreciation and amortization52 · Dec 2017 to Jun 2026
- Operating Segments50 · Dec 2018 to Jun 2026
- Allocated share based compensation expense48 · Dec 2019 to Jun 2026
- Interest income expense nonoperating net46 · Dec 2017 to Jun 2026
- Profit loss46 · Dec 2017 to Jun 2026
- Depreciation depletion and amortization42 · Dec 2019 to Jun 2026
- Income tax expense benefit42 · Dec 2017 to Jun 2026
- Other nonoperating income expense42 · Dec 2019 to Jun 2026
- Income loss from equity method investments41 · Dec 2017 to Sep 2024
- Review costs related to restatement of 2019 interim financial statements36 · Mar 2020 to Jun 2025
- Deconsolidation revaluation of retained investment gain or loss amount34 · Dec 2019 to Jun 2026
- Gain loss on derivative instruments net pretax34 · Dec 2019 to Mar 2023
- Impairment of long lived assets held for use33 · Mar 2021 to Dec 2025
- Total Assets32 · Dec 2016 to Mar 2023
- Property plant and equipment additions30 · Dec 2017 to Dec 2022
- Interest expense (US GAAP)28 · Dec 2017 to Dec 2022
- Investment income interest28 · Dec 2017 to Dec 2022
- Reportable Segment24 · Dec 2020 to Jun 2026
- Goodwill and intangible asset impairment21 · Dec 2019 to Dec 2025
- Foreign currency transaction gain loss unrealized20 · Mar 2022 to Jun 2026
- Income loss from discontinued operations net of tax20 · Dec 2018 to Dec 2021
- Restructuring charges20 · Dec 2019 to Jun 2026
- Restructuring costs18 · Mar 2022 to Jun 2026
Geography4 concepts · 170 facts · Dec 2017 to Jun 2026
- Revenue134 · Dec 2017 to Jun 2026
- Current income tax expense benefit12 · Dec 2017 to Dec 2022
- Deferred income tax expense benefit12 · Dec 2017 to Dec 2022
- Income loss from continuing operations before income taxes minority interest and income loss from equity method investments12 · Dec 2017 to Dec 2022
Product1 concepts · 125 facts · Dec 2017 to Jun 2026
- Revenue125 · Dec 2017 to Jun 2026
KPI1 concepts · 50 facts · Mar 2022 to Jun 2026
- Market Share50 · Mar 2022 to Jun 2026
Guidance2 concepts · 6 facts · Mar 2022 to May 2023
- Capital Expenditures Guidance4 · Mar 2022 to Aug 2022
- Revenue Guidance2 · May 2023
Segments
1,424 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments7 members · 1,074 facts
- Rest Of World401 · Dec 2017 to Mar 2023
- United States400 · Dec 2017 to Mar 2023
- Reportable226 · Dec 2022 to Jun 2026
- Rest of world segment20 · Dec 2019 to Mar 2023
- United states segment20 · Dec 2019 to Mar 2023
- Australia5 · Sep 2022 to Dec 2022
- Australia2 · Sep 2022 to Dec 2022
Statement geographical5 members · 166 facts
- US41 · Dec 2017 to Mar 2023
- CA39 · Dec 2017 to Jun 2026
- Other Countries36 · Dec 2017 to Jun 2026
- IL32 · Mar 2020 to Jun 2026
- Non Us18 · Dec 2017 to Dec 2022
Product or service3 members · 115 facts
- Cannabis Flower39 · Dec 2017 to Jun 2026
- Cannabis Extracts38 · Dec 2017 to Jun 2026
- Product And Service Other38 · Dec 2017 to Jun 2026
Segments4 members · 55 facts
- Operating20 · Dec 2016 to Dec 2017
- Investing19 · Dec 2016 to Dec 2017
- Investing segment8 · Dec 2016 to Dec 2017
- Operating segment8 · Dec 2016 to Dec 2017
Products and services3 members · 10 facts
- Cannabis Oils4 · Dec 2017 to Dec 2018
- Dry Cannabis4 · Dec 2017 to Dec 2018
- Other Products2 · Dec 2017 to Dec 2018
Geographical areas2 members · 4 facts
- Country Of Domicile2 · Dec 2017 to Dec 2018
- Foreign Countries2 · Dec 2017 to Dec 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.